Associated British Engineering, which is engaged in diesel and related engineering activities, has warned that sales during the financial year-to-date at its operating subsidiary, British Polar Engines, have been significantly lower on both last year's figures and on its internal budget. In a statement the firm said: 'Management cannot predict as to whether this is a trend for the year as a whole, as the level of quotations for work is currently in line with our earlier expectations and the sales over the full year may well even out.'
Angel Biotechnology, a biopharmaceutical group, has told investors that there is likely to be an adverse financial impact in the current year as a result of ongoing difficulties in the market, with a number of high value projects expected to be signed in this period, being delayed by many months as client companies seek to manage their own cash resources. The company is undergoing a planned rationalisation of its business resources that will control spend on support activities.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Are these FTSE 100 pharmaceutical stocks worth a look?Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.
-
First-time buyer mortgages that lend a handThe first rung of the property ladder can feel like more of a leap than a step – but choosing the right mortgage can help
